Drug cocktail check: will new meds mess with a diabetes pill?
NCT ID NCT07213310
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed phase 1 study tested whether two experimental drugs, DWC202511 and DWC202512, change how the body processes the diabetes medicine DWP16001. Eighteen healthy adults took DWP16001 alone and then with each of the other drugs. The goal was to see if there are any drug interactions that could affect dosing or safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DWP16001 (enavogliflozin), DWC202511, DWC202512
- What this could lead to
- If successful, this could help determine safe dosing when these drugs are taken together.
- What could go wrong
- This is a very early, small study in healthy people, not patients. Results may not predict real-world effects or safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, Jong No Gu, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test